Stockreport

Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Cytek Biosciences, Inc.  (CTKB) 
PDF FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report fi [Read more]